Sector: Health Care.Industry: Health Care Equipment & Supplies
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all its revenue from the sales of RNS System to hospitals facilities (typically Level 4 CECs) that implant RNS System.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-20
REV
Q1 2021Est.ActualSurprise
EPS-0.250-21.260 -21.0100
REV10.99011.217M11.217M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
NPCENeuroPace2.73%

NeuroPace Frequently Asked Questions

Q

How do I buy NeuroPace (NPCE) stock?

A

You can purchase shares of NeuroPace (NASDAQ: NPCE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are NeuroPace's (NPCE) competitors?

Q

What is the target price for NeuroPace (NPCE) stock?

A

The latest price target for NeuroPace (NASDAQ: NPCE) was reported by SVB Leerink on June 3, 2021. The analyst firm set a price target for 30.00 expecting NPCE to rise to within 12 months (a possible 22.80% upside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for NeuroPace (NPCE)?

A

The stock price for NeuroPace (NASDAQ: NPCE) is $24.43 last updated Today at 4:43:46 PM.

Q

Does NeuroPace (NPCE) pay a dividend?

A

There are no upcoming dividends for NeuroPace.

Q

When is NeuroPace (NASDAQ:NPCE) reporting earnings?

A
NeuroPace’s Q2 earnings are confirmed for after-market on August 20, 2021.
Q

Is NeuroPace (NPCE) going to split?

A

There is no upcoming split for NeuroPace.

Q

What sector and industry does NeuroPace (NPCE) operate in?

A

NeuroPace is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.